Related Experiment Video
Updated: Oct 28, 2026

Forming Micro-and Nano-Plastics from Agricultural Plastic Films for Employment in Fundamental Research Studies
Published on: July 27, 2022
Particle-adapted next-generation risk assessment of micro- and nanoplastics from food contact materials: Integrating
Smita Kumbhar1, Someshwar Aghav1, Omkar Kardile1
1Department of Regulatory Affairs, Sanjivani College of Pharmaceutical Education and Research, Kopargaon, 423601 Ahilyanagar, Maharashtra, India.
Abstract:
Micro- and nanoplastics (MNPs) released from food contact materials (FCMs) present a risk-assessment challenge because exposure depends not only on mass concentration but also on particle size, number, morphology, polymer identity, surface properties, aggregation, transformation, and co-migration of additives and non-intentionally added substances. Conventional approaches remain fragmented and are poorly suited to translating FCM-specific particle release into human-relevant internal dosimetry and mechanistic toxicity. This review proposes a particle-adapted next-generation risk assessment (NGRA) framework integrating FCM release characterization, gastrointestinal transformation and absorbed fraction, physiologically based toxicokinetic (PBK/PBTK) modelling, adverse outcome pathways (AOPs), and explainable artificial intelligence (XAI). The framework explicitly defines data hand-offs between modules, including particle-specific exposure metrics, internal particle burden, persistence and clearance parameters, key-event evidence, and model uncertainty. AOPs are used to organize mechanistic evidence rather than infer causality, while XAI is positioned as an interpretability and prioritization tool subject to applicability-domain assessment, external validation, reproducibility, and uncertainty analysis. Attention is given to distinguishing particle-mediated effects from those associated with co-migrating additives and non-intentionally added substances. Regulatory translation is considered in the context of FCM migration assessment and emerging NAM-based approaches. The framework provides a basis for evidence integration, testing prioritization, and future quantitative regulatory assessment of FCM-derived MNPs.

